Sort
53,477 grants matching “addiction”
Clinical Trials Network: Southwest Node
$1,095,661Barbara S McCrady · University Of New Mexico · U10 · FY2014 · DA
Dynamic Signal Processing Analyses of Neural Plasticity
$1,095,579Massachusetts General Hospital · R01 · FY2005 · DA
Patient-centered team-based primary care to Treat Opioid Use Disorder, Depression, and Other conditions
$1,095,519Lynn Larson Debar · Kaiser Foundation Research Institute · UF1 · FY2024 · MH
(Epi)genetic Risk Architectures in Opioid Dependent Brain
$1,094,363Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2017 · DA
Development of small molecule therapeutics for mitigating opioid withdrawal syndrome
$1,094,320Sid Ahmed Labed · Evodenovo, Inc. · R44 · FY2025 · DA
NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR)
$1,094,316Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · P30 · FY2014 · DA
Neurobiology of Substance Abuse & Addiction - Preclinical Studies
$1,094,310Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Impact of Marijuana Legalization: Comparison of Two Longitudinal Twin Cohorts
$1,092,978Christian J Hopfer · University Of Colorado Denver · R01 · FY2019 · DA
Clinical Trials Network: Pacific Northwest Node
$1,091,489Dennis M Donovan · University Of Washington · UG1 · FY2019 · DA
FUNCTIONAL BRAIN MAPPING OF COCAINE ACTION
$1,090,828Massachusetts General Hospital · P01 · FY2002 · DA
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes
$1,089,537Charles J Neighbors · New York University School Of Medicine · R33 · FY2025 · DA
Center for the Development of Novel Medications for Cocaine Dependence
$1,088,899Kyle Matthew Kampman · University Of Pennsylvania · U54 · FY2014 · DA
Long-lasting cocaine-metabolizing enzyme for cocaine addiction treatment
$1,088,896Chang-Guo Zhan · University Of Kentucky · R01 · FY2015 · DA
Studying NeuroHIV and addictive substances in a human microglia-neuron chimera mouse model
$1,088,600Melanie Maria Ott · J. David Gladstone Institutes · R61 · FY2025 · DA
COBRE Transitional Center in Neuroscience
$1,087,764George A Spirou · West Virginia University · P30 · FY2011 · RR
Admin - Core
$1,087,554Faye S Taxman · George Mason University · U2C · FY2023 · DA
First Human Studies of a Chimeric Anti-Methamphetamine Monoclonal Antibody
$1,087,525W Brooks Gentry · Univ Of Arkansas For Med Scis · R01 · FY2012 · DA
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$1,087,313Christopher Ramsden · National Institute On Aging · ZIA · FY2019 · AG
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$1,086,645Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2009 · DA
Prevention of Relapse in Addiction
$1,086,645Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2009 · DA
ORWH: SCOR on Sex and Gender Factors Affecting Women's Health
$1,086,584Kathleen Theresa Brady · Medical University Of South Carolina · P50 · FY2014 · DA
TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERS
$1,086,461University Of Pennsylvania · P50 · FY2000 · CA
Assessing Cultures of Recovery in Tribal Communities
$1,086,299Martina Whelshula · Healing Lodge Of The Seven Nations · S06 · FY2022 · GM
COBRE Transitional Center in Neuroscience
$1,086,005George A Spirou · West Virginia University · P30 · FY2012 · GM
NeuroTech Harbor: Optimizer #20386
$1,085,775Sridevi V. Sarma · Johns Hopkins University · U54 · FY2025 · EB